Previous studies have described and illustrated the lesions in the peripheral nerves in progressive axonopathy, an inherited neuropathy of Boxer dogs. The present paper assesses these changes using quantitative techniques. Cervical and lumbar nerve roots and tibial, phrenic and medial cutaneous radial nerves have been studied in affected and age-matched normal dogs aged 2 months to 3 years. The dorsal and ventral nerve roots, and to a lesser extent the proximal nerves, contain a proportion of swollen myelinated axons whereas in the middle and distal nerves the larger diameter fibres fail to develop to their expected maximum calibre. The unmyelinated axons remain the same size as those in normal dogs. Myelin sheath changes, with attenuation or loss of the sheath and/or remyelination, become increasingly prevalent through the course of the disease, always maintaining a proximal to distal decrease in their frequency. Quantification indicates that, particularly in the ventral roots, many axons have disproportionately thin sheaths with shortened internodes. Axonal degeneration and regeneration increase in frequency in the distal nerves as the disease progresses. The cervical ventral roots prove an exception in that they contain large numbers of regenerating clusters at most stages. It is suggested that in progressive axonopathy an axonal transport failure may occur in the roots leading to the axonal swellings, as a result of which a developmental hypoplasia occurs in the more distal, larger diameter fibres. The prominent, but unevenly distributed, myelin sheath changes indicate a severe disturbance in axon-sheath cell inter-relationships.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0022-510x(86)90051-1DOI Listing

Publication Analysis

Top Keywords

progressive axonopathy
12
axonopathy inherited
8
inherited neuropathy
8
neuropathy boxer
8
boxer dogs
8
nerve roots
8
normal dogs
8
distal nerves
8
larger diameter
8
diameter fibres
8

Similar Publications

A 40-year-old man presented to our hospital with subacute progressive muscle weakness in the limbs and leukocytosis. Subsequently, the patient was diagnosed with chronic lymphocytic leukemia (CLL) complicated by peripheral motor neuron neuropathy (axonopathy). Serology test for anti-ganglioside GM2 IgG antibody was positive, whereas paraneoplastic syndrome-related and anti-myelin-associated glycoprotein antibodies were not detected.

View Article and Find Full Text PDF
Article Synopsis
  • Pathological mutations in the Trk-fused gene (TFG) are linked to neurodegenerative diseases, particularly hereditary spastic paraplegia (HSP), causing lower limb issues.* -
  • Researchers used X-ray crystallography and cryo-electron microscopy to reveal how TFG forms octameric ring complexes, crucial for its function.* -
  • Mutations from HSP patients disrupt the stability of these complexes, leading to neurodegenerative effects, but different mutations have varying impacts, indicating multiple mechanisms of disease progression.*
View Article and Find Full Text PDF

Adrenomyeloneuropathy is a progressive neurodegenerative disease caused by pathogenic variants in the gene, resulting in very-long-chain fatty acid (VLCFA) accumulation that leads to dying-back axonopathy. Our candidate gene therapy, SBT101 (AAV9-human [h]), aims to ameliorate pathology by delivering functional copies of h to the spinal cord. Transduced cells produce functional ABCD1 protein, thereby repairing the underlying biochemical defect.

View Article and Find Full Text PDF
Article Synopsis
  • Inherited motor neuron diseases (MND) like hereditary spastic paraplegias (HSP) involve the death or dysfunction of nerve cells that control muscle activity, but genetic variants may also affect other supportive cells.
  • Researchers used a rat model with a specific TFG mutation that mimics human HSP symptoms, such as motor deficits and spasticity, to investigate the source of axonopathy in the corticospinal tract.
  • Results showed that introducing the normal TFG gene into specific neurons significantly improved motor function, while targeting supportive glial cells did not yield similar benefits, highlighting the importance of neuron-focused therapies for TFG-related HSP.
View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the loss of motoneurons (MNs), and despite progress, there is no effective treatment. A large body of evidence shows that astrocytes expressing ALS-linked mutant proteins cause non-cell autonomous toxicity of MNs. Although MNs innervate muscle fibers and ALS is characterized by the early disruption of the neuromuscular junction (NMJ) and axon degeneration, there are controversies about whether muscle contributes to non-cell-autonomous toxicity to MNs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!